As Dr Vincent Breton from the renowned CNRS-IN2P3 in Clermont-Ferrand, France, says:
The Worldwide In-Silico Docking Initiative on Malaria (WISDOM) has been very successful in docking a family of protein targets from Plasmodium falciparum against a very large subset of the ZINC compound library.
Plasmodium falciparum is a parasite transmitted by the Anopheles mosquito, responsible for malaria in humans. BioSolveIT's FlexX docking software predicts the interaction of proteins from the parasite with potential drug candidates in a few seconds. Computing coordinator Breton continues:
One of the key reasons for our success was the use of FlexX. BioSolveIT was very generous in allowing us free use of up to 1000 licenses on the grid for this large-scale deployment.
While evaluating and testing high potential compounds of phase one in wet laboratories, the consortium is preparing a second large-scale application of FlexX to combat neglected diseases. BioSolveIT is proud to be a sponsor of this initiative.